BREAKTHROUGH CANCER TREATMENT A STEP CLOSER TODAY

The National Institute for Health and Clinical Excellence (NICE) has today issued a preliminary positive recommendation (Appraisal Consultation Document) for the use of cetuximab (Erbitux®) in combination with radiotherapy for the treatment of locally advanced head and neck cancer.

PDF icon MCF080208.pdf